Transphorm, Inc.
TGAN
Revenue
4.67M
▼-340.00k▼-6.79%
3 Months ChangeAssets
32.66M
▼-1.63M▼-4.74%
3 Months ChangeLiabilities
14.41M
▲3.81M▲35.99%
3 Months ChangeFree Cash Flow
-8.77M
▼-3.14M▼-55.66%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-06-20
Form 8-K
ID: 0001193125-24-164045
2024-04-10
Form 8-K
ID: 0001193125-24-092038
2024-03-05
Form 8-K
ID: 0001193125-24-059278
2024-02-20
Form 10-Q
ID: 0001715768-24-000009
2024-02-20
Form 8-K
ID: 0001715768-24-000008
2024-01-11
Form 8-K
ID: 0001193125-24-006329
2023-12-28
Form 8-K
ID: 0001715768-23-000112
2023-11-13
Form 10-Q
ID: 0001715768-23-000108
2023-11-09
Form 8-K
ID: 0001715768-23-000104
2023-10-11
Form 8-K
ID: 0001715768-23-000094